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by Elsevier B.V. This is an open accesAbstract Background and objectives: The prevalence of methicillin-resistant Staphylococcus
aureus (MRSA) infections has been steadily increasing. These infections are considered to be
either hospital-acquired MRSA (HA-MRSA) or community-acquired MRSA (CA-MRSA). Children
are at higher risk of infection than adults. HA-MRSA has been reported to have more serious
outcomes than CA-MRSA. However, there are not enough studies in Saudi Arabia to study the
characteristics of HA-MRSA in children. We aim to describe the characteristics of HA-MRSA
infection, including risk factors, culture site, clinical manifestations, complications, and out-
comes among pediatric patients in a tertiary care hospital in Riyadh, Saudi Arabia.
Design and settings: This is a retrospective chart review study. It was conducted in King Abdu-
laziz medical city in Riyadh.
Patients and methods: The study included all patients 14 years of age or younger who were
culture-positive from any site in the body during the period from January 1, 2009 to December
31, 2011. The time of culture compared to admission time was used to differentiate between
CA-MRSA (within 72 h of admission) and HA-MRSA (more than 72 h after admission). The final
sample size was 39 patients.
Results: We found HA-MRSA to be more common in males and those with risk factors such as
previous surgery and previous hospitalization. Patients had a high Pediatric intensive care unit
(PICU) admission rate and were commonly septic with positive blood cultures. Seventy-four
percent of patients fully recovered, 10% recovered with complications and 15% died.laziz Medical City (KAMC), Riyadh, Saudi Arabia. Tel.: +966 500121366 (Saudi mobile number),
ber).
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72 K. Alrabiah et al.Conclusion: HA-MRSA is an infection that can cause serious complications and a high rate of
PICU admissions. Clinical manifestations such as shock are associated with higher mortality
and morbidity rates. Special care should be given to those admitted to PICU, as they have high
rates of mortality and morbidity.
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The incidence of methicillin-resistant Staphylococcus
aureus (MRSA) infection has been steadily increasing. This
has coincided with an increase in the number of patients
presenting with serious invasive disease due to MRSA [1,2].
The causative organisms are defined as Staphylococcus
aureus strains with an oxacillin minimum inhibitory con-
centration (MIC) of at least 4 mcg/mL. MRSA is resistant to
all beta-lactam agents, including cephalosporins (with the
exception of ceftobiprole) [3]. Its resistance is derived from
the mecA gene encoding for the low-affinity binding protein
PBP-2a, which allows the organism to grow and divide in the
presence of methicillin and other beta-lactam antibiotics
[4,5]. Due to its high resistance to previously mentioned
antibiotics and the appearance of new strains, MRSA
infection has become an increasing medical challenge
[6e9]. Infections caused by MRSA have been classified as
either nosocomial (hospital acquired) or community ac-
quired [2,8,10]. Infection is considered to be HA-MRSA if
positive cultures result from samples drawn after 72 h of
admission. Cases considered CA-MRSA include those in
which positive cultures have been drawn outside the
hospital or drawn within 72 h of admission or in cases in
which MRSA was diagnosed in an outpatient setting
[8,11,12].
Although MRSA infection rates are not significant in
countries such as the Netherlands, Denmark, and Sweden
[13,14], the threat has increased significantly in many other
countries, such as the USA and Western European countries
such as Great Britain, in which MRSA infection has become
an epidemic [11,12,14,15]. Furthermore, some Middle
Eastern countries such as Iran have recorded high numbers
of MRSA infections [16]. Children are at risk of acquiring
MRSA infections [17e19]. The risk increases more when
they have co-morbidities such as malignancies, recent
surgeries, autoimmune diseases, previous antibiotic usage,
and long-term hospitalization, with resultant exposure to
potentially more dangerous strains of HA-MRSA [17,19e21].
Moreover, the threat of MRSA infection has increased in
children and has manifested more frequently in neonates
and in countries such as the U.S [22,23]. Risk factors for
children are the same as for adults, with the addition of
genetic diseases such as cystic fibrosis and congenital im-
munodeficiencies [17,20,24].
The first report of MRSA in Saudi Arabia was published in
1994 by Zaman in the western region in Jeddah. Over a
period of three years covering Zaman’s report, he found
that 7.5% of all Staphylococcus aureus infections were MRSA
positive [25]. Thereafter, a few reports followed fromMadani and others in 2002 in the setting of two tertiary care
centers in Saudi Arabia. The studies included patients from
adult and pediatric wards (both medical and surgical). They
found that 33% of all Staphylococcus aureus cultured pa-
tients were MRSA positive [11,12]. Despite these data,
studies describing MRSA infections in the pediatric popula-
tion in Saudi Arabia remain limited in number. Only one
study [18] exclusively described pediatric MRSA infections
in Saudi Arabia. Bukhari et al investigated 80 previously
healthy pediatric patients with community acquired MRSA
infection and found that 6% (five patients) had invasive CA-
MRSA with serious complications that included osteomye-
litis, deep vein thrombosis, and subdural empyema [18].
The growing risk of MRSA was reported by Bukharie and
Abdelhadi from King Fahd University Hospital in Dammam,
Saudi Arabia in a study showing that the prevalence of CA-
MRSA infections increased from 9.9 per 10,000 admissions in
2001 to 67 per 10,000 admissions in 2008 [8,13].
Rates of MRSA infection are increasing among the Saudi
population, including children. The data on pediatric HA-
MRSA are limited, but signs indicate that it is also becoming
more frequent [2,6e8,11e13,18,26,27]. These data dem-
onstrates that MRSA infection in the pediatric population
needs to be studied further. The aim of this study is to
describe characteristics of pediatric HA-MRSA infection in a
tertiary care hospital in King Abdulaziz Medical City,
Riyadh, Saudi Arabia, and determine possible risk factors,
in hope that it will add to the body of knowledge on this
important infection in this region.
2. Patients and methods
This is a case series retrospective chart review study that
was conducted at King Abdulaziz Medical City in Riyadh, a
tertiary care center with approximately 1000 beds. It
included all patients who were 14 years of age or younger
with a documented culture of MRSA from any site of the
body between January 2009 and December 2011. Data on
patients with MRSA were retrieved from the database of the
Infection Prevention and Control Department at our insti-
tution, which performs approximately 900 polymerase
chain reaction (PCR) screenings per month. The MRSA policy
at KAMC-Riyadh is to screen all patients who are:
 Admitted to the Pediatric intensive care unit (PICU).
 Transferred from another hospital or treated in another
hospital within the last six months.
 Undergoing cardiac, orthopedic (including spine) sur-
gery, preoperatively.
Table 1 Patient demographics (n Z 39)
Number Percent
Age category
Up to 1 year 18 46%
1 to 5 years 11 28%







Characteristics and risk factors of hospital acquired 73 Hemodialysis patients on admission for the first dialysis
treatment and for placement of any type of vascular
access (i.e.: AV-fistula, permanent catheter, graft, or
port access device).
 Patients on continuous ambulatory peritoneal dialysis
treatment for the first time when scheduled for catheter
placement.
 Known to be previously MRSA positive.
 Roommates of MRSA-positive patients not on isolation
precautions.
The sites to screen include:
 Anterior nares.
 Non-intact skin areas (e.g., tracheostomy, pressure
sores, or surgical wounds).
 The groin and axillae of neonates and pediatric patients
awaiting liver or cardiac surgery.
Presentations of MRSA infection that were included in
the study were abscess, signs of shock (hypotension,
tachycardia, etc.), discharge from any site of the body,
fever, respiratory distress, localized swelling, etc. We
considered only the first isolate of bacterial culture results.
The time of culture was used to differentiate between CA-
MRSA (less than 72 h of admission) and HA-MRSA (more than
72 h after admission). Patient data including age, gender,
nationality, risk factors, clinical manifestation, culture
site, unit of stay, diagnosis, and outcome were retrieved
from patient charts into the data collection sheet. Data
were then entered and analyzed using a software statistical
package (SPSS version 20). Outcomes were divided into
favorable (complete recovery) and unfavorable (recovery
with complications or death). Patient confidentiality during
data collection and entry was ensured using a coding sys-
tem that prevented disclosure of names or medical record
numbers. Statistical methods used to obtain our objectives
included the mean, median, standard deviation, minimum,
maximum age, and Chi-Square for categorical data. The
results were then transferred to Microsoft Office Excel 2007
to create several charts and diagrams (Table 1, Figs. 1e7).
3. Results
Two hundred patients were documented to have MRSA
infection. After analyzing the data, we found that nearly
one-quarter (22%, 39 patients) of MRSA-infected patients
had HA-MRSA. The majority of patients in our study were
males (59%, 23 patients), with 40% females (16 patients)
(Table 1). The majority of our sample were Saudis (95%, 37
patients) (Table 1). We categorized the pediatric popula-
tion studied into three age groups (below one year, be-
tween one and five years, and more than five years). Nearly
half of the patients were below one year old (46%, 18 pa-
tients), with 26% (11 patients) between one and five years,
and 28% (10 patients) above five years of age (Table 1). The
mean age was 3.1 years of age, with a maximum of 12 years
and a minimum of nine days. Most of our population had
previous surgery (31%, 12 patients), previous hospitalization
(26%, 10 patients), or a cardiac anomaly (23%, nine pa-
tients) (Fig. 1). Other co-morbidities included conditionssuch as asthma, burns, renal failure, or metabolic diseases
(Fig. 1). 59% (23 patients) presented with fever. 38% (15
patients) presented with skin and soft tissue infection
(SSTI) manifestations. And 23% (9 patients) presented with
abscess (Fig. 2). Shock manifestations (hypotension,
tachycardia, etc.) were found in 21% (8 patients) (Fig. 2). In
19 infected patients (52%), the site of HA-MRSA isolation
was blood in 31% (12 patients), skin and soft tissue in 13% (4
patients), and bone or joint in 8% (3 patients) (Fig. 3). Other
less frequently reported sites among our study population
included CSF and lumbar drain catheter in two patients (5%)
and tip of central venous catheter in one patient (3%)
(Fig. 3). We found that 12 patients (31%) were admitted to
the PICU, 10 patients (26%) were admitted to the pediatric
ward, and five patients each (13% each) were admitted to
the burn unit, NICU and cardiac CCU (Fig. 4). Twelve pa-
tients (31%) were diagnosed with septicemia, seven pa-
tients (18%) had pneumonia, and six patients (15%) had
cellulitis (Fig. 5). We attempted to correlate the time of
year with the rate of infection, but we were unable to
establish a relationship. Twenty-nine (74%) of the studied
patients fully recovered (Fig. 6). Among the remaining pa-
tients (10%, four patients) recovered with complications
such as vision impairment, and six patients (15%) died
(Fig. 6). We tried to find an association between unfavor-
able outcomes and co-morbidities associated with HA-MRSA
infection and found that unfavorable outcomes were asso-
ciated with chronic pulmonary diseases such as asthma (P-
Value Z .03) (Fig. 7). Eighty percent of patients with un-
favorable outcomes (eight patients) required PICU care and
presented with shock manifestations and/or SSTI
manifestations.
4. Discussion
The threat of MRSA infection has been increasing on a na-
tional and global basis [2,23]. MRSA infections are consid-
ered to be HA-MRSA if positive culture samples are drawn
after 72 h of admission. Cases of CA-MRSA infection include
patients from whom cultures have been withdrawn outside
the hospital or for whom diagnosis occurred in an outpa-
tient setting [8,11,12]. The epidemiological characteristics
of HA-MRSA infections vary among geographic regions and
from one year to another. A recently published study con-
ducted in Pennsylvania by Casy et al indicated that
Fig. 1 Comorbidities and associated risk factors.
Fig. 2 Clinical presentation (n = 39).
Fig. 3 Site of isolation (n Z 39).
Fig. 4 Unit of stay (n Z 39).
Fig. 5 Presenting diagnosis (n Z 39).
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Fig. 6 Outcome (n Z 39).
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has increased by 7% [28]. We tried to compare some of
our research results to other studies conducted at a similar
time in other regions. We found that the risk of acquiring
HA-MRSA increased with younger age, with a median age of
3.1 years. The finding was correlated with a study con-
ducted in Minnesota, USA, where the mean age of infection
was 2.4 years [29].
We found that patients under one year of age had the
highest rate of admission due to HA-MRSA (46%, 18 patients)
(Table 1). This concurred with the findings of a study con-
ducted by Gutierrez and others in California, USA, indi-
cating that from 1985 to 2009, those under one year of age
had a higher hospitalization rate than did children 1e2
years of age (OR 5.6) [23].
The PICU had the highest rate of admission in our study
31% (12 patients) (Fig. 4). This correlated with results of an
MRSA review study conducted at Johns Hopkins Hospital in
the United States by David MZ et al. This study found that
from 2007 to 2008, 6% (72/1674) of patients in their PICU
had MRSA colonization [30].
A 2013 study conducted in Pakistan to investigate nasal
colonization among septicemia patients found that nasalFig. 7 Corelation between risk fascreening for MRSA colonization can be helpful in deter-
mining the cause of septicemia. The same study detected
MRSA infections in 100% of those on dialysis or with surgical
site infections [31]. We reported that septicemia (31%, 12
patients) and pneumonia (18%, seven patients) were among
the most common consequences of HA-MRSA infection in
our study (Fig. 5). Similarly, a 2013 study from China by Wu
X et al reported that children who acquired HA-MRSA had an
aggressive infection course associated most frequently with
pneumonia and septicemia. However, the same study
indicated that CNS infections were common, whereas in our
study, it was rare (6%, two patients) (Fig. 5) [32]. We did
not find a correlation between time of year and infection
rates in our study. In contrast, a study conducted in the USA
to investigate the epidemiological change of MRSA in-
fections found that the infection frequency was highest
between the months of June to October. The same study
reported that rates of blood stream and pneumonia-related
admissions had not changed compared to data they had
collected previously. Additionally, most patients in the
study had strains of HA-MRSA [33]. Another study, con-
ducted by Leonard M. Mermel et al, reported that children
exhibited a seasonal pattern of HA-MRSA infection, whereas
adult infections exhibited no such seasonality [34].
We think that the spread of nosocomial can be reduced
or even eliminated by implementing and enhancing general
infection control and prevention measures, including hand
hygiene. Pereira et al published results of a 2014 study that
was conducted in Botucatu, Brazil which concluded that
improving hygiene practices in high risk areas such as the
PICU and NICU would help to prevent infection [35].
5. Conclusion
HA-MRSA is a serious infection with variable epidemiology
that presents the need for further investigation within this
geographic region. Young children and children with risk
factors, especially those involving pulmonary disease, tendctors and outcomes (n Z 39).
76 K. Alrabiah et al.to have worse prognoses than those who do not. HA-MRSA is
responsible for a high number of PICU and NICU admissions.
It has been shown in our study to cause serious complica-
tions and adverse outcomes, especially for those who
require PICU admission. This study emphasizes the need for
surveillance of patients who are admitted with HA-MRSA
infection. Strict Infection control measures must always be
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